Novel roles for factor XII-driven plasma contact activation system

Area of Science:

• Coagulation and Thrombosis
• Inflammation Biology
• Vascular Biology

Background:

• Blood coagulation is a complex process involving endothelium, platelets, and plasma factors.
• Fibrin formation occurs via sequential proteolytic reactions initiated by extrinsic and intrinsic pathways.
• The physiological role of factor XII, initiating the intrinsic pathway, remains unclear due to lack of associated disease in deficiency states.

Purpose of the Study:

• To review recent findings on the factor XII-driven contact activation system.
• To explore the roles of factor XII in coagulation, inflammation, and edema.
• To assess the therapeutic potential of targeting the contact system.

Main Methods:

• Analysis of patient studies and genetically altered mouse models.
• In vitro plasma assays to study contact activation system functions.
• Phenotypization of animals deficient in contact system proteins (factor XII, factor XI, high-molecular-weight kininogen).

Main Results:

• Factor XII deficiency protects against arterial thrombus formation without impacting hemostasis.
• Novel in-vivo activators of factor XII have been identified.
• Factor XII plays a role in edema formation and its downstream protease, factor XI, has identified functions.

Conclusions:

• Recent research has enhanced understanding of the factor XII contact system in hemostasis, thrombosis, and inflammation.
• Targeting contact system proteins presents opportunities for safe anticoagulation with reduced bleeding risk.
• Inhibition of factor XII activity may serve as a therapeutic strategy for managing edema.